Cutaneous delivery of [1-(4-chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol, an indole-3-carbinol derivative, mitigates psoriasiform lesion by blocking MAPK/NF-kappa B/AP-1 activation

Weng, JR; Huang, TH; Lin, ZC; Alalaiwe, A; Fang, JY

Fang, JY (reprint author), Chang Gung Univ, Grad Inst Nat Prod, Pharmaceut Lab, 259 Wen Hwa 1stRd, Taoyuan 333, Taiwan.

BIOMEDICINE & PHARMACOTHERAPY, 2019; 119 ():